![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Eulgem KC, Knitza R. 2000. Konservative Behandlungsmöglichkeiten ektoper Schwangerschaften und Präsentation eines komplizierten Verlaufes mit einer Peritonitis unter Methotrexat. Gynäkologisch-Geburtshilfliche Rundschau 40:159–162.
- Guideline Trophoblastic Disease Version 3.0. Werkgroep Oncologische Gynaecologie (WOG). 2017; Available from: https://www.nvog.nl/wp-content/uploads/2018/03/Richtlijn-trofoblastziekten.pdf [Accessed June 2019].
- Sachdev A, Usatoff V, Thaow C. 2006. Sclerosing encapsulating peritonitis and methotrexate. Australian and New Zealand Journal of Obstetrics and Gynaecology 46:58–66.
- Sharma S, Jagdev S, Coleman RE, Hancock BW, Lorigan PC. 1999. Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis. British Journal of Cancer 81:1037–1041.
- Ureyen I, Ilgin H, Karalok A, Tapisiz O, Turan T, Boran N, et al. 2013. Methotrexate-induced peritonitis: case report. Asian Pacific Journal of Reproduction 2:82–84.
- Zimmermann S, Zaman K, Wolfer A, Jacot W. 2012. Severe peritonitis induced by methotrexate during treatment of persistent gestational trophoblastic disease. The Oncologist 17:e18–e20.